(20) demonstrated that genes involved in chromatin remodeling (including BAP1, ARID1A, and PBRM1), which was considered as the frequently targeted pathway in CCA, were somatically altered in almost half of the intrahepatic CCA cases. This evidence concerns the gene PBRM1 and cholangiocarcinoma.